RegisterLogin

Tofacitinib-13C3

CAT: 0804-HY-40354SSize: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-40354SSize:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Tofacitinib-13C3 is the 13C-labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
Product Name Alternative
Tasocitinib-13C3; CP-690550-13C3
UNSPSC
12352005
Target
Apoptosis; JAK
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/tofacitinib-13c3.html
Purity
99.77
Solubility
10 mM in DMSO
Smiles
O=[13C]([13CH2][13C]#N)N1C[C@H](N(C2=C3C(NC=C3)=NC=N2)C)[C@H](C)CC1
Molecular Formula
C13 13C3H20N6O
Molecular Weight
315.35
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Jiang JK, et al. Examining the chirality, conformation and selective kinase inhibition of 3- ((3R,4R) -4-methyl-3- (methyl (7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino) piperidin-1-yl) -3-oxopropanenitrile (CP-690,550) . J Med Chem. 2008 Dec 25;51 (24) :8012-8.|[3]Onda M, et al. Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts. J Immunol. 2014 Jul 1;193 (1) :48-55.|[4]LaBranche TP, et al. JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. Arthritis Rheum. 2012 Nov;64 (11) :3531-42.|[5]Calama E, et al. Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS. Pulm Pharmacol Ther. 2017 Apr;43:60-67.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-40354S3Tofacitinib-13C
HY-40354S2Tofacitinib-13C, d3
HY-40354-01Tofacitinib
HY-40354A-01Tofacitinib (citrate)
HY-40354S5Tofacitinib-d3
HY-40354R-01Tofacitinib (Standard)
HY-78558-01Tofacitinib Impurity T
HY-40354AR-01Tofacitinib (citrate) (Standard)
HY-40354D-01(3R,4S) -Tofacitinib
HY-40354B-01(3S,4R) -Tofacitinib

Alternative Products

CatalogName
RM-T060605-01[13C3,15N]-Tofacitinib
166225Rac CP-690550 Citrate-13C3-15N (rac-Tofacitinib 13C3-15N Citrate) discontinued
MBS3842227-01Tofacitinib
KL-01-00300-01Tofacitinib Citrate
T70168-01Tofacitinib HCl
MBS5778178-01rac-Tofacitinib
bs-75613C-01Tofacitinib . citrate
MBS5812501Tofacitinib maleate
A17252-100Tofacitinib 100mg

Popular Products